ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.55
-0.90 (-7.86%)
Jul 25, 2025, 3:46 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 81.60 million as of July 25, 2025. Its market cap has increased by 91.83% in one year.
Market Cap
81.60M
Enterprise Value
75.67M
Revenue
6.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.55
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 81.60M, a decrease of -68.52%. That is a compound annual growth rate of -15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 81.60M | -0.47% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | 254.51M | 144.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,984.48B |
| Coloplast | 139.69B |
| Genmab | 92.41B |
| Demant | 59.43B |
| ALK-Abelló | 43.68B |
| H. Lundbeck | 33.97B |
| Zealand Pharma | 27.46B |
| Ambu A/S | 27.25B |